Share this post on:

Product Name :
Setmelanotide Acetate

Search keywords :
MC4R

drugId :
null

Target Vo:
Melanocortin receptor 4

Target Vo Short Name :
MC4R

Moa_Name:
Melanocortin receptor 4 agonists

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Ipsen

Active Company_Name :
Ipsen Inc

Active Indication_Name:
Bardet-Biedl Syndrome

In Active Indication_Name:
Obesity, Morbid

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Siltuximab Immunology/Inflammation
Transferrin Receptor 1 Antibody Epigenetics
PCNA Antibody: PCNA Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 29 kDa, targeting to PCNA. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Betaine hydrochloride